| Primary |
| Product Used For Unknown Indication |
39.6% |
| Drug Use For Unknown Indication |
12.8% |
| Lower Respiratory Tract Infection |
6.0% |
| Helicobacter Infection |
4.5% |
| Hypertension |
3.7% |
| Intentional Overdose |
3.2% |
| Ear Infection |
2.6% |
| Sinusitis |
2.6% |
| Urinary Tract Infection |
2.4% |
| Infection |
2.4% |
| Helicobacter Gastritis |
2.3% |
| Asthma |
2.3% |
| Upper Respiratory Tract Infection |
2.2% |
| Pneumonia |
2.1% |
| Bronchitis |
2.0% |
| Tooth Abscess |
2.0% |
| Pyrexia |
1.9% |
| Tooth Infection |
1.9% |
| Respiratory Tract Infection |
1.8% |
| Pharyngitis |
1.7% |
|
| Urticaria |
14.7% |
| Rash |
11.8% |
| Vomiting |
11.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.5% |
| Drug Hypersensitivity |
5.7% |
| Pruritus |
5.3% |
| Toxic Epidermal Necrolysis |
4.4% |
| Swelling Face |
4.3% |
| Weight Decreased |
3.9% |
| Diarrhoea |
3.7% |
| Renal Failure Acute |
3.6% |
| Swollen Tongue |
3.5% |
| Nausea |
2.9% |
| Anaphylactic Reaction |
2.8% |
| Rhabdomyolysis |
2.8% |
| White Blood Cell Count Increased |
2.7% |
| Medication Error |
2.6% |
| Rash Generalised |
2.5% |
| Stevens-johnson Syndrome |
2.5% |
| Pyrexia |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
33.0% |
| Helicobacter Infection |
17.2% |
| Drug Use For Unknown Indication |
15.9% |
| Pyrexia |
3.8% |
| Hypertension |
3.6% |
| Foetal Exposure During Pregnancy |
3.2% |
| Asthma |
2.4% |
| Gastric Ulcer |
2.2% |
| Pain |
2.1% |
| Urinary Tract Infection |
1.7% |
| Infection |
1.7% |
| Helicobacter Gastritis |
1.6% |
| Intentional Overdose |
1.6% |
| Lower Respiratory Tract Infection |
1.6% |
| Prophylaxis |
1.6% |
| Depression |
1.5% |
| Suicide Attempt |
1.3% |
| Bronchitis |
1.3% |
| Cough |
1.3% |
| Ear Infection |
1.2% |
|
| Vomiting |
12.1% |
| Drug Hypersensitivity |
9.2% |
| Toxic Epidermal Necrolysis |
8.6% |
| Urticaria |
7.3% |
| Stevens-johnson Syndrome |
6.4% |
| Rash |
5.4% |
| Renal Failure Acute |
5.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.5% |
| Pyrexia |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Diarrhoea |
3.9% |
| Weight Decreased |
3.9% |
| Hypoglycaemia |
3.8% |
| Rhabdomyolysis |
3.6% |
| Suicide Attempt |
3.2% |
| Toxic Skin Eruption |
3.2% |
| Maternal Exposure During Pregnancy |
3.1% |
| Cytolytic Hepatitis |
2.9% |
| Nausea |
2.6% |
| Pruritus |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.1% |
| Drug Use For Unknown Indication |
15.8% |
| Pain |
5.7% |
| Hypertension |
4.8% |
| Depression |
4.7% |
| Prophylaxis |
4.6% |
| Contraception |
4.2% |
| Multiple Myeloma |
3.7% |
| Asthma |
2.8% |
| Anxiety |
2.7% |
| Rheumatoid Arthritis |
2.6% |
| Osteoporosis |
2.4% |
| Acne |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Sinusitis |
1.7% |
| Metastases To Bone |
1.7% |
| Helicobacter Infection |
1.6% |
| Bronchitis |
1.6% |
| Breast Cancer |
1.6% |
| Infection |
1.6% |
|
| Vomiting |
16.2% |
| Weight Decreased |
14.8% |
| Pulmonary Embolism |
7.9% |
| Pain |
7.6% |
| Urinary Tract Infection |
4.5% |
| Pyrexia |
4.3% |
| Deep Vein Thrombosis |
4.2% |
| Weight Increased |
3.9% |
| Tooth Extraction |
3.9% |
| Ventricular Septal Defect |
3.7% |
| Thrombocytopenia |
3.4% |
| Pneumonia |
3.4% |
| Nausea |
3.2% |
| Anxiety |
2.8% |
| Wheezing |
2.8% |
| Rash |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Renal Failure Acute |
2.7% |
| Vertigo |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
19.2% |
| Helicobacter Infection |
9.6% |
| Drug Use For Unknown Indication |
7.0% |
| Infection |
6.1% |
| Ear Infection |
5.2% |
| Jaw Fracture |
5.2% |
| Atrial Fibrillation |
4.8% |
| Lower Respiratory Tract Infection |
4.4% |
| Gastric Ulcer |
3.9% |
| Pneumonia |
3.9% |
| Contraception |
3.5% |
| Hypertension |
3.5% |
| Pharyngitis |
3.5% |
| Pulmonary Arterial Hypertension |
3.5% |
| Epilepsy |
3.1% |
| Parkinson's Disease |
3.1% |
| Analgesic Therapy |
2.6% |
| Liver Transplant Rejection |
2.6% |
| Pulmonary Hypertension |
2.6% |
| Thrombosis Prophylaxis |
2.6% |
|
| Drug Interaction |
25.0% |
| International Normalised Ratio Increased |
7.9% |
| Liver Function Test Abnormal |
7.9% |
| Urinary Tract Infection |
6.6% |
| Thrombocytopenia |
5.3% |
| Anaphylactic Reaction |
3.9% |
| Coagulopathy |
3.9% |
| Haemolytic Uraemic Syndrome |
3.9% |
| Overdose |
3.9% |
| Rectal Haemorrhage |
3.9% |
| Vomiting |
3.9% |
| Dizziness |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Hepatitis |
2.6% |
| Hepatomegaly |
2.6% |
| Hypoglycaemia |
2.6% |
| Inhibitory Drug Interaction |
2.6% |
| Road Traffic Accident |
2.6% |
| Somnolence |
2.6% |
| Subcutaneous Haematoma |
2.6% |
|
